Jieying Amelia Lau

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

Tuan Zea Tan, Qing Hao Miow, Ruby Yun‐Ju Huang et al. · EMBO Molecular Medicine · 2013 · 291 citations · Full text

Medicine, Molecular Biology, Oncology +17

Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer

Qing Hao Miow, Tuan Zea Tan, Jieru Ye et al. · Oncogene · 2014 · 116 citations

Medicine, Cancer Biology, Oncology +12

Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients

Ling-Zhi Wang, Jacqueline Ramı́rez, Winnie Yeo et al. · PLoS ONE · 2013 · 66 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

A novel combinatorial strategy using Seliciclib® and Belinostat® for eradication of non-small cell lung cancer via apoptosis induction and BID activation

Pei-Shi Ong, Lingzhi Wang, Deborah Miao-Hui Chia et al. · Cancer Letters · 2016 · 42 citations

Medicine, Oncology, Pharmacology +17

Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation

Li Ren Kong, Richard Ong, Tuan Zea Tan et al. · Nature Communications · 2020 · 30 citations · Full text

Medicine, Genetics, Oncology +17